Related Experiment Video
Updated: Jun 1, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
p54nrb is a new regulator of progression of malignant melanoma
Susanne Schiffner1, Nicole Zimara, Rainer Schmid
1Institute of Pathology, Molecular Pathology, University of Regensburg Medical School, Regensburg, Germany.
Abstract:
Nuclear RNA-binding protein p54(nrb) and its murine homolog NonO are known to be involved in a variety of nuclear processes including transcription and RNA processing. Melanoma inhibitory activity (MIA) has been shown to play an essential role in the progression of malignant melanoma and to influence melanoma-associated molecules and pathways in the early tumor formation steps. Interestingly, recent studies suggest that MIA is a regulator of p54(nrb). Here, we show that p54(nrb) is strongly expressed and localized in the nucleus of both melanoma cell lines and melanoma tissue samples compared with normal human melanocytes or normal skin, respectively. Furthermore, all tested melanoma cell lines revealed strong p54(nrb) promoter activity. Treatment with MIA-specific small interfering RNAs showed an influence of MIA on p54(nrb) expression on both messenger RNA (mRNA) and protein level. Knockdown of p54(nrb) protein in melanoma cell lines led to reduced proliferation rates and to a strong decrease in their migratory potential. In addition, attachment to laminin and poly-l-lysine was significantly increased. We could identify Connexin-43 (Cx-43) as a downstream target molecule of p54(nrb) as knockdown of p54(nrb) resulted in enhanced Cx-43 mRNA and protein levels. As a confirmation of these findings, melanoma cell lines showed very low Cx-43 expression levels compared with melanocytes. Our results demonstrate that p54(nrb) is highly expressed in malignant melanoma and, as a MIA target molecule, it seems to be involved in the development and progression of malignant melanoma.
Insights
Nuclear RNA-binding protein p54(nrb) is highly expressed in melanoma and regulates cell proliferation and migration. Melanoma inhibitory activity (MIA) influences p54(nrb) expression, suggesting a role in melanoma development.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Nuclear RNA-binding protein p54(nrb) (also known as NonO) participates in nuclear processes like transcription and RNA processing.
- Melanoma inhibitory activity (MIA) is crucial for malignant melanoma progression and influences early tumor formation pathways.
- Emerging evidence suggests MIA regulates p54(nrb).
Purpose of the Study:
- To investigate the role of p54(nrb) in malignant melanoma.
- To explore the relationship between MIA and p54(nrb) expression and function in melanoma.
- To identify downstream targets of p54(nrb) in melanoma.
Main Methods:
- Immunohistochemistry on melanoma cell lines and tissues.
- Reporter assays to measure p54(nrb) promoter activity.
- Small interfering RNA (siRNA) knockdown of MIA and p54(nrb).
- Analysis of cell proliferation, migration, and attachment.
- Quantitative analysis of Connexin-43 (Cx-43) mRNA and protein levels.
Main Results:
- p54(nrb) exhibits high expression and nuclear localization in melanoma cells and tissues compared to normal melanocytes and skin.
- MIA knockdown influences p54(nrb) expression at both mRNA and protein levels.
- p54(nrb) knockdown reduces melanoma cell proliferation and migration while increasing attachment to laminin and poly-l-lysine.
- Connexin-43 (Cx-43) is identified as a downstream target of p54(nrb), with its expression inversely correlated in melanoma cells versus melanocytes.
Conclusions:
- p54(nrb) is significantly overexpressed in malignant melanoma.
- MIA regulates p54(nrb) expression.
- p54(nrb) plays a critical role in melanoma cell proliferation, migration, and potentially adhesion.
- p54(nrb) influences the expression of Connexin-43, a molecule with altered levels in melanoma.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...